About DNASense
DNASense is a Healthcare company based in Aalborg (Denmark) founded in 2014 by Mads Albertsen, and was acquired by Clinical Microbiomics in March 2024. Genetic engineering services including sequencing and metagenomics are provided. The company has 8 employees. Its chief executive, as recorded, is Mads Albertsen. DNASense offers products and services including Microbial marker gene analysis, Genomics, Metagenomics, Metatranscriptomics, and Microbial source tracking. Its focus areas include Life Sciences, Genomics, Genomics Services and Full Service. Its legal entity is DNASENSE APS.
Company details
DNASense was established in 2014 in Aalborg, Denmark, within the biotechnology sector. Genetic engineering services are delivered by the company, covering bacteria and archaea community profiling, fungi community profiling, sequencing, metagenomics, bioinformatics analysis, gene expression profiling, and biobank operations. These activities support research and analysis in microbial and genetic fields across various applications.
- Headquarters Aalborg, Denmark
- Employees 8
- Founders Mads Albertsen
- Stage Acquired
- SectorsHealthcare
- Emailβ’β’β’β’β’β’β’β’
- Phoneβ’β’β’β’ β’β’β’β’
- Website dnasense.com
- Social LinkedIn X
- Acquired by Clinical Microbiomics (Mar 2024)
- Legal Name Dnasense Aps
- Investors
- Employee Count8
- Acquired byClinical Microbiomics
(Mar 2024)
Products & Services of DNASense
DNASense offers a comprehensive portfolio of products and services, including Microbial marker gene analysis, Genomics, Metagenomics, Metatranscriptomics, and Microbial source tracking.
Targeted sequencing to identify microbial communities and their abundance.
Provides annotated microbial genomes for metabolic potential analysis.
Whole-genome sequencing to uncover microbial community structures.
RNA sequencing for quantifying transcripts in microbial samples.
Sequencing to track and pinpoint sources of microbial outbreaks.
Assists with data sharing and figure customization for publications.
Investors in DNASense
DNASense has secured backing from 1 investor. Prominent investors backing the company include Clinical Microbiomics.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Meta-genomics platforms and services for microbiome studies are provided. | 2016 | clinical-microbiomics.com | Horsholm, Denmark |
Investor details for DNASense
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of DNASense
1 people are tracked at DNASense (1 in leadership); the tracked headcount is 8.
| Name | Role | Group |
|---|---|---|
Mads Albertsen | Co-Founder & CEO | Leadership |
Complete people profiles for DNASense
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of DNASense
2 dated milestones of DNASense across 10 years, from founding to its latest funding, stage changes and deals.
- Founded DNASense is founded.
- Exit Acquired by Clinical Microbiomics.
Web traffic of DNASense
The website of DNASense (dnasense.com) receives about 2.7K visits a month.
- Monthly visits2.7K
▲ 9.3% vs previous month
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Dnasense
Complete news archive for DNASense
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about DNASense
DNASense was founded in 2014.
DNASense is headquartered in Aalborg, Denmark.
Mads Albertsen is the CEO of DNASense, as recorded in our data. They have also founded this company.
DNASense has 8 employees.
DNASense was established in 2014 in Aalborg, Denmark, within the biotechnology sector. Genetic engineering services are delivered by the company, covering bacteria and archaea community profiling, fungi community profiling, sequencing, metagenomics, bioinformatics analysis, gene expression profiling, and biobank operations. These activities support research and analysis in microbial and genetic fields across various applications.
DNASense offers Microbial marker gene analysis, Genomics, Metagenomics, Metatranscriptomics, and 2 more products and services.
DNASense has 1 investor. Key investors include Clinical Microbiomics.
DNASense operates through Dnasense Aps.
Yes. DNASense was acquired by Clinical Microbiomics in March 2024.

